101 related articles for article (PubMed ID: 22310721)
1. Comparative autoantibody profiling before and after appearance of malignance: identification of anti-cathepsin D autoantibody as a promising diagnostic marker for lung cancer.
Luo X; Lu F; Wang HL; Wang N; Li WH; Guo N; Wang HX; Xia Q
Biochem Biophys Res Commun; 2012 Apr; 420(4):704-9. PubMed ID: 22310721
[TBL] [Abstract][Full Text] [Related]
2. Proteomics-based identification of autoantibody against heat shock protein 70 as a diagnostic marker in esophageal squamous cell carcinoma.
Fujita Y; Nakanishi T; Miyamoto Y; Hiramatsu M; Mabuchi H; Miyamoto A; Shimizu A; Takubo T; Tanigawa N
Cancer Lett; 2008 May; 263(2):280-90. PubMed ID: 18334280
[TBL] [Abstract][Full Text] [Related]
3. [Proteome analysis of autoantibodies in sera of patients with cancer].
Ueda K
Rinsho Byori; 2005 May; 53(5):437-45. PubMed ID: 15966408
[TBL] [Abstract][Full Text] [Related]
4. Proteomics-based approach identifying autoantibody against peroxiredoxin VI as a novel serum marker in esophageal squamous cell carcinoma.
Fujita Y; Nakanishi T; Hiramatsu M; Mabuchi H; Miyamoto Y; Miyamoto A; Shimizu A; Tanigawa N
Clin Cancer Res; 2006 Nov; 12(21):6415-20. PubMed ID: 17085654
[TBL] [Abstract][Full Text] [Related]
5. Identification of lung cancer patients by serum protein profiling using surface-enhanced laser desorption/ionization time-of-flight mass spectrometry.
Han KQ; Huang G; Gao CF; Wang XL; Ma B; Sun LQ; Wei ZJ
Am J Clin Oncol; 2008 Apr; 31(2):133-9. PubMed ID: 18391596
[TBL] [Abstract][Full Text] [Related]
6. Identification of an anti-aldolase autoantibody as a diagnostic marker for diabetic retinopathy by immunoproteomic analysis.
Ahn BY; Song ES; Cho YJ; Kwon OW; Kim JK; Lee NG
Proteomics; 2006 Feb; 6(4):1200-9. PubMed ID: 16421937
[TBL] [Abstract][Full Text] [Related]
7. Cathepsin D is secreted from M-BE cells: its potential role as a biomarker of lung cancer.
Lou X; Xiao T; Zhao K; Wang H; Zheng H; Lin D; Lu Y; Gao Y; Cheng S; Liu S; Xu N
J Proteome Res; 2007 Mar; 6(3):1083-92. PubMed ID: 17284061
[TBL] [Abstract][Full Text] [Related]
8. An autoantibody-mediated immune response to calreticulin isoforms in pancreatic cancer.
Hong SH; Misek DE; Wang H; Puravs E; Giordano TJ; Greenson JK; Brenner DE; Simeone DM; Logsdon CD; Hanash SM
Cancer Res; 2004 Aug; 64(15):5504-10. PubMed ID: 15289361
[TBL] [Abstract][Full Text] [Related]
9. Dickkopf-1 autoantibody is a novel serological biomarker for non-small cell lung cancer.
Yao X; Jiang H; Zhang C; Wang H; Yang L; Yu Y; Yu J; Shi B; Shen Z; Gao H; Chen Z; Tian S; Lu S; Li Z; Gu J
Biomarkers; 2010 Mar; 15(2):128-34. PubMed ID: 19839718
[TBL] [Abstract][Full Text] [Related]
10. Anti-alpha-enolase autoantibodies are down-regulated in advanced cancer patients.
Shih NY; Lai HL; Chang GC; Lin HC; Wu YC; Liu JM; Liu KJ; Tseng SW
Jpn J Clin Oncol; 2010 Jul; 40(7):663-9. PubMed ID: 20395242
[TBL] [Abstract][Full Text] [Related]
11. Detection of autoantibodies against cyclophilin A and triosephosphate isomerase in sera from breast cancer patients by proteomic analysis.
Tamesa MS; Kuramitsu Y; Fujimoto M; Maeda N; Nagashima Y; Tanaka T; Yamamoto S; Oka M; Nakamura K
Electrophoresis; 2009 Jun; 30(12):2168-81. PubMed ID: 19582718
[TBL] [Abstract][Full Text] [Related]
12. Humoral immune responses to cathepsin D and glucose-regulated protein 78 in ovarian cancer patients.
Chinni SR; Falchetto R; Gercel-Taylor C; Shabanowitz J; Hunt DF; Taylor DD
Clin Cancer Res; 1997 Sep; 3(9):1557-64. PubMed ID: 9815843
[TBL] [Abstract][Full Text] [Related]
13. Development of a "reverse capture" autoantibody microarray for studies of antigen-autoantibody profiling.
Qin S; Qiu W; Ehrlich JR; Ferdinand AS; Richie JP; O'leary MP; Lee ML; Liu BC
Proteomics; 2006 May; 6(10):3199-209. PubMed ID: 16596707
[TBL] [Abstract][Full Text] [Related]
14. Development of autoantibody signatures as novel diagnostic biomarkers of non-small cell lung cancer.
Wu L; Chang W; Zhao J; Yu Y; Tan X; Su T; Zhao L; Huang S; Liu S; Cao G
Clin Cancer Res; 2010 Jul; 16(14):3760-8. PubMed ID: 20501620
[TBL] [Abstract][Full Text] [Related]
15. Epitope recognition by anti-cathepsin D autoantibodies in endometrial cancer patients.
Bosscher JR; Gerçel-Taylor C; Watkins CS; Taylor DD
Gynecol Oncol; 2001 May; 81(2):138-43. PubMed ID: 11330940
[TBL] [Abstract][Full Text] [Related]
16. Serum-autoantibodies for discovery of prostate cancer specific biomarkers.
Massoner P; Lueking A; Goehler H; Höpfner A; Kowald A; Kugler KG; Amersdorfer P; Horninger W; Bartsch G; Schulz-Knappe P; Klocker H
Prostate; 2012 Mar; 72(4):427-36. PubMed ID: 22012634
[TBL] [Abstract][Full Text] [Related]
17. Autoantibodies against tumor-associated antigens in the early detection of lung cancer.
Dai L; Tsay JC; Li J; Yie TA; Munger JS; Pass H; Rom WN; Zhang Y; Tan EM; Zhang JY
Lung Cancer; 2016 Sep; 99():172-9. PubMed ID: 27565936
[TBL] [Abstract][Full Text] [Related]
18. [Autoantibodies against tumor-related antigens: new tools for early detection of lung cancer].
Solassol J; Harmand PO; Maudelonde T; Pujol JL
Bull Cancer; 2011 Dec; 98(12):1419-30. PubMed ID: 22146366
[TBL] [Abstract][Full Text] [Related]
19. Autoantibody to tumor antigen, alpha 2-HS glycoprotein: a novel biomarker of breast cancer screening and diagnosis.
Yi JK; Chang JW; Han W; Lee JW; Ko E; Kim DH; Bae JY; Yu J; Lee C; Yu MH; Noh DY
Cancer Epidemiol Biomarkers Prev; 2009 May; 18(5):1357-64. PubMed ID: 19423516
[TBL] [Abstract][Full Text] [Related]
20. Anti-tumor and anti-ovarian autoantibodies in women with ovarian cancer.
Barua A; Bradaric MJ; Kebede T; Espionosa S; Edassery SL; Bitterman P; Rotmensch J; Luborsky JL
Am J Reprod Immunol; 2007 Apr; 57(4):243-9. PubMed ID: 17362385
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
